Free Trial

CryoPort (CYRX) Competitors

CryoPort logo
$7.29 -0.37 (-4.83%)
As of 04:00 PM Eastern

CYRX vs. EVO, OCUL, SDGR, BHVN, ETNB, ANIP, MESO, EWTX, JANX, and TVTX

Should you be buying CryoPort stock or one of its competitors? The main competitors of CryoPort include Evotec (EVO), Ocular Therapeutix (OCUL), Schrodinger (SDGR), Biohaven (BHVN), 89BIO (ETNB), ANI Pharmaceuticals (ANIP), Mesoblast (MESO), Edgewise Therapeutics (EWTX), Janux Therapeutics (JANX), and Travere Therapeutics (TVTX). These companies are all part of the "pharmaceutical products" industry.

CryoPort vs. Its Competitors

Evotec (NASDAQ:EVO) and CryoPort (NASDAQ:CYRX) are both small-cap pharmaceutical products companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, dividends, profitability, media sentiment, valuation, institutional ownership, analyst recommendations and earnings.

CryoPort has lower revenue, but higher earnings than Evotec.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Evotec$862.40M1.72-$212.18MN/AN/A
CryoPort$228.38M1.60-$114.76M-$2.34-3.12

Evotec has a net margin of -26.34% compared to CryoPort's net margin of -50.15%. CryoPort's return on equity of -11.03% beat Evotec's return on equity.

Company Net Margins Return on Equity Return on Assets
Evotec-26.34% -21.51% -10.54%
CryoPort -50.15%-11.03%-5.54%

Evotec presently has a consensus target price of $5.93, suggesting a potential upside of 41.95%. CryoPort has a consensus target price of $10.88, suggesting a potential upside of 49.18%. Given CryoPort's stronger consensus rating and higher possible upside, analysts plainly believe CryoPort is more favorable than Evotec.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Evotec
0 Sell rating(s)
3 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.40
CryoPort
0 Sell rating(s)
2 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.75

5.8% of Evotec shares are owned by institutional investors. Comparatively, 92.9% of CryoPort shares are owned by institutional investors. 10.1% of CryoPort shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Evotec has a beta of 1.66, indicating that its stock price is 66% more volatile than the S&P 500. Comparatively, CryoPort has a beta of 1.89, indicating that its stock price is 89% more volatile than the S&P 500.

In the previous week, CryoPort had 3 more articles in the media than Evotec. MarketBeat recorded 4 mentions for CryoPort and 1 mentions for Evotec. Evotec's average media sentiment score of 1.13 beat CryoPort's score of 0.63 indicating that Evotec is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Evotec
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
CryoPort
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

CryoPort beats Evotec on 10 of the 14 factors compared between the two stocks.

Get CryoPort News Delivered to You Automatically

Sign up to receive the latest news and ratings for CYRX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CYRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CYRX vs. The Competition

MetricCryoPortTRANS IndustryTransportation SectorNASDAQ Exchange
Market Cap$384.05M$5.79B$7.19B$9.03B
Dividend YieldN/A2.28%914.35%4.07%
P/E Ratio-3.1210.5712.8720.03
Price / Sales1.601.20320.75108.98
Price / CashN/A10.827.5228.59
Price / Book0.982.932.095.55
Net Income-$114.76M$189.74M$563.51M$248.49M
7 Day Performance-2.28%-0.95%2.07%5.37%
1 Month Performance4.14%0.80%3.73%6.63%
1 Year Performance12.50%-3.42%2.67%21.20%

CryoPort Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CYRX
CryoPort
2.9124 of 5 stars
$7.29
-4.8%
$10.88
+49.2%
+17.9%$384.05M$228.38M-3.121,186Analyst Forecast
Gap Down
EVO
Evotec
1.669 of 5 stars
$4.20
+1.0%
$5.93
+41.3%
-20.8%$1.49B$862.40M0.004,827Positive News
OCUL
Ocular Therapeutix
3.9153 of 5 stars
$9.28
+0.7%
$17.33
+86.8%
+40.3%$1.48B$59.65M-8.07230Positive News
SDGR
Schrodinger
2.7962 of 5 stars
$20.12
-2.4%
$32.80
+63.0%
+1.2%$1.48B$207.54M-7.65790High Trading Volume
BHVN
Biohaven
3.1537 of 5 stars
$14.11
+0.1%
$58.46
+314.3%
-57.1%$1.44BN/A-1.51239
ETNB
89BIO
1.5516 of 5 stars
$9.82
-0.4%
$26.43
+169.1%
+34.8%$1.43BN/A-2.9140
ANIP
ANI Pharmaceuticals
3.6248 of 5 stars
$65.25
-0.4%
$80.13
+22.8%
+6.3%$1.41B$614.38M-51.38600
MESO
Mesoblast
2.1038 of 5 stars
$10.89
-0.3%
$18.00
+65.3%
+39.4%$1.39B$5.67M0.0080Positive News
EWTX
Edgewise Therapeutics
2.6256 of 5 stars
$13.11
-0.5%
$40.00
+205.1%
-33.3%$1.38BN/A-8.4660
JANX
Janux Therapeutics
1.536 of 5 stars
$23.10
-0.2%
$95.25
+312.3%
-38.5%$1.37B$10.59M-16.9930
TVTX
Travere Therapeutics
3.148 of 5 stars
$14.80
+0.2%
$32.14
+117.2%
+90.1%$1.31B$233.18M-5.27460

Related Companies and Tools


This page (NASDAQ:CYRX) was last updated on 7/7/2025 by MarketBeat.com Staff
From Our Partners